Goldman Sachs’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.08M Sell
534,715
-574,046
-52% -$12.3M ﹤0.01% 3148
2025
Q4
$28.5M Sell
1,108,761
-431,651
-28% -$9.93M ﹤0.01% 2039
2025
Q3
$33.1M Buy
1,540,412
+36,116
+2% +$821K ﹤0.01% 1779
2025
Q2
$33.1M Buy
1,504,296
+314,517
+26% +$6.9M ﹤0.01% 1671
2025
Q1
$26.6M Sell
1,189,779
-1,246,125
-51% -$26.8M ﹤0.01% 1757
2024
Q4
$42M Buy
2,435,904
+1,012,046
+71% +$15.7M 0.01% 1449
2024
Q3
$23.9M Buy
1,423,858
+713,403
+100% +$17.1M ﹤0.01% 1906
2024
Q2
$20.3M Buy
710,455
+370,956
+109% +$11.2M ﹤0.01% 1876
2024
Q1
$13M Buy
339,499
+15,486
+5% +$585K ﹤0.01% 2239
2023
Q4
$12M Sell
324,013
-451,786
-58% -$15.2M ﹤0.01% 2359
2023
Q3
$26.4M Buy
775,799
+172,225
+29% +$6.5M 0.01% 1569
2023
Q2
$23.7M Buy
603,574
+134,977
+29% +$4.87M 0.01% 1706
2023
Q1
$15.1M Buy
468,597
+127,778
+37% +$4.22M ﹤0.01% 2060
2022
Q4
$10.6M Sell
340,819
-58,252
-15% -$2.11M ﹤0.01% 2524
2022
Q3
$14.8M Buy
399,071
+49,667
+14% +$1.86M ﹤0.01% 2132
2022
Q2
$10.2M Buy
349,404
+5,864
+2% +$210K ﹤0.01% 2500
2022
Q1
$17.7M Sell
343,540
-34,624
-9% -$1.48M ﹤0.01% 2150
2021
Q4
$19M Sell
378,164
-48,049
-11% -$2.69M ﹤0.01% 2151
2021
Q3
$23.9M Buy
426,213
+288,491
+209% +$15.9M 0.01% 1908
2021
Q2
$8.13M Sell
137,722
-5,317
-4% -$299K ﹤0.01% 2889
2021
Q1
$6.37M Buy
143,039
+37,202
+35% +$1.74M ﹤0.01% 2925
2020
Q4
$4.49M Buy
105,837
+28,542
+37% +$928K ﹤0.01% 3084
2020
Q3
$2.27M Buy
77,295
+39,968
+107% +$1.1M ﹤0.01% 3472
2020
Q2
$964K Buy
37,327
+25,996
+229% +$597K ﹤0.01% 3980
2020
Q1
$240K Buy
+11,331
New +$311K ﹤0.01% 4615

Other funds holding PGNY

Goldman Sachs's PGNY Position: Q1 2026 in Review

Goldman Sachs reduced its Progyny (PGNY) stake by 52% in Q1 2026, selling an estimated $12.3M and leaving 534,715 shares worth $9.08M. The position accounts for ﹤0.01% of the portfolio, ranked #3148.

Goldman Sachs first reported a position in PGNY in Q1 2020 and has held it in 25 quarters since. The position peaked at $42M in Q4 2024. 292 funds tracked by Wall St. Rank hold PGNY as of Q1 2026.

  • Goldman Sachs held 534,715 shares of Progyny worth $9.08M as of Q1 2026.
  • Goldman Sachs sold 574,046 Progyny shares in Q1 2026, an estimated $12.3M.
  • Progyny made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3148 holding.
  • Goldman Sachs first reported a position in Progyny in Q1 2020 and has held it in 25 quarters since.
  • Goldman Sachs's Progyny position peaked at $42M in Q4 2024.
  • 292 funds tracked by Wall St. Rank held Progyny as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.